Myocardial remodelling induced by repeated low doses of isoproterenol

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 8, 2009, Pages 641-651

  Mikušová, Andrea ^a   Kráľová, Eva ^b   Tylková, Lucia ^a   Novotová, Marta ^a   Stankovičová, Tatiana ^b  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

Contractile dysfunction; ECG; Heart; Hypertrophy; Isoproterenol; Mitochondria; Plasma membrane; T tubules; Ultrastructure

Indexed keywords

ISOPRENALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAVEOLA; CELL MEMBRANE; CELL SURVIVAL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOARCHITECTURE; DIASTOLIC BLOOD PRESSURE; ELECTRON MICROSCOPY; HEART BEAT; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART RATE; HEART VENTRICLE HYPERTROPHY; ISOLATED HEART; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; QT PROLONGATION; RAT; RIBOSOME; ROUGH ENDOPLASMIC RETICULUM; SYSTOLIC BLOOD PRESSURE; TRANSVERSE TUBULAR SYSTEM;

ANIMALS; CARDIOTONIC AGENTS; DRUG ADMINISTRATION SCHEDULE; HEMODYNAMICS; HYPERTROPHY, LEFT VENTRICULAR; INJECTIONS, SUBCUTANEOUS; ISOPROTERENOL; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; VENTRICULAR REMODELING;

EID: 70349113127     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-053     Document Type: Article

References (40)

1. Baillard, C., Mansier, P., Ennezat, P.V., Mangin, L., Medigue, C., Swynghedauw, B., and Chevalier, B. 2000. Converting enzyme inhibition normalizes QT interval in spontaneously hypertensive rats. Hypertension, 36(3): 350-354. PMID:10988263.
2. Di Maio, A., Karko, K., Snopko, R.M., Mejía-Alvarez, R., and Franzini-Armstrong, C. 2007. T-tubule formation in cardiacmyocytes: two possible mechanisms? J. Muscle Res. Cell Motil. 28(4-5): 231-241. doi:10.1007/s10974- 007-9121-x. PMID:17940841.
3. Diwan, A., and Dorn, G.-W., 2nd. 2007. Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda), 22: 56-64. PMID:17289931.
4. Dresel, P.E., and Hart, M.C. 1963. Cardiac arrhythmias induced by injection of isoproterenol into the coronary arteries. J. Pharmacol. Exp. Ther. 140: 67-75.
5. + exchanger inhibition. Hypertension, 41(6): 1324-1329. doi:10.1161/01.HYP.0000071180.12012.6E. PMID:12732584.
6. Gima, K., and Rudy, Y. 2002. Ionic current basis of electrocardiographic waveforms: a model study. Circ. Res. 90(8): 889-896. doi:10.1161/01.RES. 0000016960.61087.86. PMID:11988490.
7. Goldspink, D.F., Burniston, J.G., Ellison, G.M., Clark, W.A., and Tan, L.-B. 2004. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp. Physiol. 89(4): 407-416. doi:10.1113/expphysiol.2004.027482. PMID:15131072.
8. Goto, Y., Yoshikane, H., Honda, M., Morioka, S., Yamori, Y., and Moriyama, K. 1990. Three-dimensional observation on sarcoplasmic reticulum and caveolae in myocardium of spontaneously hypertensive rats. J. Submicrosc. Cytol. Pathol. 22(4): 535-542. PMID:2149305.
9. Handforth, C.P. 1962. Isoproterenol-induced myocardial infarction in animals. Arch. Pathol. 73: 161-165. PMID:13904308.
10. Haunstetter, A., and Izumo, S. 2000. Toward antiapoptosis as a new treatment modality. Circ. Res. 86(4): 371-376. PMID:10700440.
11. Head, B.P., Patel, H.H., Roth, D.M., Murray, F., Swaney, J.S., Niesman, I.R., et al. 2006. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J. Biol. Chem. 281(36): 26391-26399. doi:10.1074/jbc.M602577200. PMID:16818493.
12. Janse, M.J. 2004. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc. Res. 61(2): 208-217. doi:10.1016/j.cardiores.2003.11.018. PMID:14736537.
13. Kahn, D.S., Rona, G., and Chappel, C.I. 1969. Isoproterenol-induced cardiac necrosis. Ann. N. Y. Acad. Sci. 156(1): 285-293. doi:10.1111/j.1749- 6632.1969.tb16735.x. PMID:5291138.
14. Kikuchi, T., Oka, N., Koga, A., Miyazaki, H., Ohmura, H., and Imaizumi, T. 2005. Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy. J. Cardiovasc. Pharmacol. 45(3): 204-210. doi:10.1097/01.fjc. 0000152029.53997.57. PMID:15725944.
15. Kim, H.D., Kim, D.J., Lee, I.J., Rah, B.J., Sawa, Y., and Schaper, J. 1992. Human fetal heart development after mid-term: morphometry and ultrastructural study. J. Mol. Cell. Cardiol. 24(9): 949-965. doi:10.1016/0022-2828(92)91862-Y. PMID:1433323.
16. Králová, E., Mokrán, T., Murín, J., and Stankovicová, T. 2008. Electrocardiography in two models of isoproterenol-induced left ventricular remodeling. Physiol. Res. 57(Suppl 2): S83-S89. PMID:18373388.
17. Křenek, P., Klimas, J., Krošláková, M., Gažová, A., Plandorová, J., Kučerová, D., et al. 2006. Increased expression of endothelial nitric oxide synthase and caveolin-1 in the aorta of rats with isoproterenol-induced cardiac hypertrophy. Can. J. Physiol. Pharmacol. 84(12): 1245-1250. doi:10.1139/Y06-073. PMID:17487232.
18. Leenen, F.H.H., White, R., and Yuan, B. 2001. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am. J. Physiol. Heart Circ. Physiol. 281(6): H2410-H2416. PMID:11709406.
19. 1. Mol. Genet. Metab. 71(1-2): 418-435. doi:10.1006/mgme.2000.3032. PMID:11001836.
20. Mészáros, J., and Lévai, G. 1990. Ultrastructural and electrophysiological alterations during the development of catecholamine-induced cardiac hypertrophy and failure. Acta Biol. Hung. 41(4): 289-307. PMID:2151869.
21. Mészáros, J., and Pásztor, B. 1995. Effect of ouabain in catecholamine-induced cardiac hypertrophy. Acta Physiol. Hung. 83(1): 55-62. PMID:7660838.
22. Mészáros, J., Khananshvili, D., and Hart, G. 2001. Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats. Am. J. Physiol. Heart Circ. Physiol. 281(2): H903-H914. PMID:11454597.
23. Nagano, M., Higaki, J., Nakamura, F., Higashimori, K., Nagano, N., Mikami, H., and Ogihara, T. 1992. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension, 19(6 Pt 2): 708-712. PMID:1534315.
24. Norman, J.E., Jr., and Levy, D. 1995. Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. J. Am. Coll. Cardiol. 26(4): 1022-1029. doi:10.1016/0735-1097(95)00269-5. PMID:7560595.
25. Ocaranza, M.P., Díaz-Araya, G., Chiong, M., Muñoz, D., Riveros, J.P., Ebensperger, R., et al. 2002. Isoproterenol and angiotensin I-converting enzyme in lung, left ventricle, and plasma during myocardial hypertrophy and fibrosis. J. Cardiovasc. Pharmacol. 40(2): 246-254. doi: 10.1097/00005344-200208000-00010. PMID:12131554.
26. Oikarinen, L., Nieminen, M.S., Viitasalo, M., Toivonen, L., Jern, S., Dahlöf, B., et al.LIFE Study Investigators. 2004. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension Study. Hypertension, 43(5): 1029-1034. doi:10.1161/01.HYP.0000125230.46080.c6. PMID:15037560.
27. Okin, P.M., Devereux, R.B., Jern, S., Kjeldsen, S.E., Julius, S., Nieminen, M.S., et al.Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study Investigators. 2003. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Circulation, 108(6): 684-690. doi:10.1161/01.CIR.0000083724.28630.C3. PMID:12885747.
28. Ozaki, M., Kawashima, S., Yamashita, T., Hirase, T., Ohashi, Y., Inoue, N., et al. 2002. Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ. J. 66(9): 851-856. doi:10.1253/circj.66.851. PMID:12224825.
29. Rakusan, K., Tietzová, H., Poupa, O., and Turek, Z. 1965. Cardiomegaly after repeated application of isoprenalin in the rat. Physiol. Bohemoslov. 14(5): 456-459. PMID:4222055.
30. Schwartz, A. (Editor). 1971. Methods in pharmacology. Vol. 1. Appleton-Century-Crofts, Meredith, New York. pp. 131-138.
31. Shipsey, S.J., Bryant, S.M., and Hart, G. 1997. Effects of hypertrophy on regional action potential characteristics in the rat left ventricle: a cellular basis for T-wave inversion? Circulation, 96(6): 2061-2068. PMID:9323099.
32. 2+ sparks and cellular distribution of ryanodine receptors in developing cardiomyocytes from rat. J. Mol. Cell. Cardiol. 44(6): 1032-1044. doi:10.1016/j.yjmcc.2008.03.015. PMID:18468619.
33. Suzuki, M., Ohte, N., Wang, Z.-M., Williams, D.L., Jr., Little, W.C., and Cheng, C.P. 1998. Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy. Cardiovasc. Res. 39(3): 589-599. doi:10.1016/S0008-6363(98)00166-7. PMID:9861301.
34. Swynghedauw, B. 2005. [The acquired long QT during cardiac hypertrophy: origin, incidence and significance]. Bull. Acad Natl. Med. 189(1): 31-40, discussion 40-42. PMID:16119878.
35. Swynghedauw, B., Baillard, C., and Milliez, P. 2003. The lon QT interval is not only inherited but is also linked to cardiac hypertrophy. J. Mol. Med. 81(6): 336-345. PMID:12750820.
36. Wang, X., Ren, B., Liu, S., Sentex, E., Tappia, P.S., and Dhalla, N.S. 2003. Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J. Appl. Physiol. 94(2): 752-763. PMID:12531914.
37. Yan, G.X., and Antzelevitch, C. 1998. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation, 98(18): 1928-1936. PMID:9799215.
38. Zhang, G.X., Kimura, S., Nishiyama, A., Shokoji, T., Rahman, M., Yao, L., et al. 2005. Cardiac oxidative stress in acute and chronic isoproterenol- infused rats. Cardiovasc. Res. 65(1): 230-238. doi:10.1016/j.cardiores.2004.08. 013. PMID:15621051.
39. Zhang, Y.G., Li, Y.G., Liu, B.G., Wei, R.H., Wang, D.M., Tan, X.R., et al. 2007. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol. Acta Pharmacol. Sin. 28(1): 36-43. doi:10.1111/j.1745-7254.2006.00485.x. PMID:17184580.
40. Zimmer, H.G. 1997. Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression. J. Mol. Med. 75(11-12): 849-859. doi:10.1007/s001090050176. PMID:9428617.